SNWV stock forecast, quote, news & analysis
SANUWAVE Health Inc is a medical device company providing directed energy products into the wound care space... Show more
Why SANUWAVE Health (SNWV) Stock Is Up +15.8% in the Last 30 Days
Key Takeaways
- SANUWAVE Health (SNWV) shares climbed about 15.8% over the trailing 30 days, rebounding from near a 52-week low.
- The move lifted the stock from $4.55 to $5.27, though it remains far below its 52-week high of $36.20.
- The rally reflects a recovery in a small-cap name that has been under sustained selling pressure, with a roughly 84% decline over the past 52 weeks.
- Key risks include a Nasdaq continued-listing notice disclosed in late September and a longer-term downtrend that has persisted through much of 2026.
- Upcoming earnings, listing compliance, and reimbursement trends in advanced wound care are central to the outlook.
SANUWAVE Health (SNWV) Company Overview and Market Position
SANUWAVE Health, Inc. is a Minnesota-based medical device company that develops and markets directed-energy, non-invasive ultrasound technology for regenerative medicine and wound care. Its flagship product, the UltraMIST system, uses low-frequency, non-contact ultrasound to promote the repair and regeneration of tissue, musculoskeletal, and vascular structures, and is used in the treatment of acute and chronic wounds. The company, led by Chief Executive Officer Morgan C. Frank, reported trailing-twelve-month revenue of approximately $44 million, with gross margins historically above 75%.
Investors follow SNWV for its position in the advanced wound care segment, its growing base of installed systems, and its efforts to expand adoption across long-term care and mobile wound care settings. As a micro-cap stock with limited float and a five-year beta of roughly 1.42, the shares tend to exhibit significantly higher volatility than the broader market.
SANUWAVE Health (SNWV) Stock Price Performance: Last 30 Days vs. Quarter
Over the trailing 30 days, SNWV advanced from a closing price of $4.55 to $5.27, a gain of approximately 15.8%. This rebound followed a period in which the stock touched a 52-week low of $3.92 in early September. The recovery has been uneven, marked by choppy trading and wide intraday swings typical of a low-float, lower-liquidity security.
Over the broader quarter, the picture is different. SNWV traded near $6.40 in mid-July before falling sharply, and the stock remains roughly 17% below that level despite the recent 30-day bounce. The multi-month trend has been defined by a steep July selloff, continued pressure into September, and only a partial stabilization since. Against a 52-week high of $36.20, the shares remain down approximately 84% over the past year.
What Drove SNWV Stock Price in the Last 30 Days
The 30-day advance appears driven primarily by a technical rebound from depressed levels rather than a single, clearly identified positive catalyst. After reaching its 52-week low in early September, SNWV attracted renewed buying interest, recovering from deeply oversold conditions in a stock with elevated volatility and a relatively small public float.
The move occurred against a mixed news backdrop. In late September, the company disclosed in an 8-K filing a notice related to a Nasdaq continued-listing requirement, a development that highlights ongoing listing-compliance risk even as the shares recovered. Broader sentiment around small-cap healthcare names and opportunistic trading in beaten-down medical device stocks also contributed to choppy, two-way price action during the period.
What Drove SNWV Stock Performance Over the Last Quarter
The quarterly trend has been dominated by a sharp downward repricing that began in July. After trading above $11 in early July, the stock fell rapidly through the middle of the month on significantly elevated volume, eventually settling below $6.50. This multi-month slide extended into September, when the stock set its 52-week low.
Several factors have shaped the broader narrative. The company posted record first-quarter revenue of $9.6 million in its Q1 2026 report, but also an operating loss and pressure on gross margin tied to a shift toward wholesale pricing. Management has cited unexpected CMS pricing changes that caused a temporary disruption in the advanced wound care market earlier in the year. Combined with the Nasdaq listing notice and a 52-week decline of roughly 84%, these developments have kept investor confidence fragile, even as the stock staged a partial recovery over the past month.
Trending AI Robots
For traders seeking a systematic approach to navigating volatile small-cap stocks, Tickeron's Trending AI Robots page offers a curated view of AI-driven trading strategies. Tickeron hosts hundreds of AI trading bots that monitor thousands of tickers, but only the top-performing and most relevant bots are featured in this section. These bots differ in strategy, trading timeframe, and performance metrics, giving users a range of approaches to evaluate rather than a one-size-fits-all signal. The page is designed to help traders discover automated tools that align with their own objectives and risk tolerance, serving as a starting point for further research into data-driven trading.
SNWV Stock Forecast Drivers: What Investors Should Watch Next
Investors will likely focus on several forward-looking factors. The company's next quarterly earnings report and updated revenue guidance will be closely watched, particularly whether consumables utilization and system placements continue to grow and whether gross margin stabilizes after the shift to wholesale pricing. Resolution of the Nasdaq continued-listing matter is another key near-term consideration.
At the industry level, reimbursement and CMS pricing dynamics in advanced wound care remain a central swing factor, as do adoption trends across long-term care and large national accounts. The company's balance sheet, including its cash position and outstanding debt, will also matter for assessing operating flexibility. As a low-float micro-cap with above-average beta, SNWV is likely to remain subject to sharp price swings driven by sentiment and liquidity as much as by fundamentals.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Aroon Indicator for SNWV shows an upward move is likely
SNWV's Aroon Indicator triggered a bullish signal on October 21, 2026. Tickeron's A.I.dvisor detected that the AroonUp green line is above 70 while the AroonDown red line is below 30. When the up indicator moves above 70 and the down indicator remains below 30, it is a sign that the stock could be setting up for a bullish move. Traders may want to buy the stock or look to buy calls options. A.I.dvisor looked at 83 similar instances where the Aroon Indicator showed a similar pattern. In 78 of the 83 cases, the stock moved higher in the days that followed. This puts the odds of a move higher at 90%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 45 of 55 cases where SNWV's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 82%.
SNWV moved above its 50-day moving average on October 06, 2026 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for SNWV crossed bullishly above the 50-day moving average on October 08, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 13 of 15 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 87%.
Following a +10.56% 3-day Advance, the price is estimated to grow further. Considering data from situations where SNWV advanced for three days, in 157 of 193 cases, the price rose further within the following month. The odds of a continued upward trend are 81%.
Bearish Trend Analysis
The 10-day RSI Indicator for SNWV moved out of overbought territory on October 13, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 14 similar instances where the indicator moved out of overbought territory. In 12 of the 14 cases, the stock moved lower in the following days. This puts the odds of a move lower at 86%.
The Momentum Indicator moved below the 0 level on October 21, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on SNWV as a result. In 120 of 129 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 90%.
The Moving Average Convergence Divergence Histogram (MACD) for SNWV turned negative on October 19, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 69 similar instances when the indicator turned negative. In 67 of the 69 cases the stock turned lower in the days that followed. This puts the odds of success at 90%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where SNWV declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.
SNWV broke above its upper Bollinger Band on October 06, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
Fundamental Analysis (Ratings)
The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Valuation Rating of 62 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (16.359) is normal, around the industry mean (2.923). P/E Ratio (2.978) is within average values for comparable stocks, (2.388). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (11.052). Dividend Yield (0.000) settles around the average of (0.009) among similar stocks. P/S Ratio (0.873) is also within normal values, averaging (40.124).
The Tickeron Price Growth Rating for this company is 64 (best 1 - 100 worst), indicating fairly steady price growth. SNWV’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 96 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. SNWV’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.
Notable companies
Industry description
Market Cap
High and low price notable news
Volume
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Advertisement
General Information
Industry MedicalNursingServices